SleepHealthU Logo
Treatment of Chronic Insomnia

    Release date: January 29, 2008

    Expiration date: January 29, 2009

    Estimated time to complete activity: 1.25 hours

    Jointly sponsored by Curatio CME Institute LLC and AXIOM Professional Health Learning

    Support for this activity has been provided through educational grants from Cephalon, sanofi-aventis U.S. Inc., and Takeda.

    Curatio  Axiom

    Support for this activity has been provided through by an educational grant from Cephalon, sanofi-aventis U.S. Inc., and Takeda.

    Cephalon sanofi-aventis Takeda

    Activity Overview
    Despite its prevalence, insomnia is often underdiagnosed and undertreated. A recent poll found that only 4% of the population was treated for insomnia yet approximately one-third of the population suffers from insomnia symptoms (Doghramji PP, 2004 p23).

    Treating insomnia can be a complex process. Psychological, behavioral, lifestyle, environmental, and physiological factors can all contribute to insomnia, so therapeutic strategies may focus on any or all of these areas (Winkelman JW, 2005 p7).

    This activity will educate primary care physicians how to effectively treat patients for chronic insomnia.

    Target Audience
    This activity has been designed to meet the educational needs of primary care physicians.

    Learning Objectives
    Upon completion of this activity, participants should be able to:

    . Identify psychological and behavioral strategies for the treatment of insomnia
    . Discuss advantages and limitations of psychological and behavioral therapies for treatment of insomnia
    . Describe pharmacologic agents for the treatment of insomnia
    . Discuss efficacy and adverse effects of different pharmacologic agents

    Faculty

    Larry Culpepper, MD, MPH
    Professor and Chair, Department of Family Medicine
    Boston University
    Boston, Massachusetts


    Chief, Division of Family Medicine
    Boston Medical Center
    Boston, Massachusetts

    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Curatio CME Institute and AXIOM Professional Health Learning. Curatio CME Institute is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    Curatio CME Institute designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Method of Participation
    There are no fees for participating in this CME activity. To receive credit during the period January 29, 2008 to January 29, 2009, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form including the certificate information section.

    You will then be able to print or store your AMA PRA Category 1 certificate for this activity. Please e-mail any questions to cmeinfo@curatiocme.com.

    Medium
    The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

    Disclosure
    In accordance with the ACCME’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

    Larry Culpepper, MD, MPH has disclosed the following relevant financial relationships:

    Consultant

    Forest Laboratories Inc., Neurocrine Biosciences Inc., Pfizer Inc., Takeda, Wyeth Pharmaceuticals

    Speaker

    Forest Laboratories, Pfizer Inc., Wyeth Pharmaceuticals

    Dr. Culpepper will not discuss the unlabeled or investigational use of a commercial product.

    AXIOM Professional Health Learning
    Anita Infante, PhD, Medical Writer, has disclosed no relevant financial relationships.

    Curatio CME Institute
    Denise C. LaTemple, PhD, Vice President, Scientific Services, has disclosed no relevant financial relationships.

    Brett Mutschler, CME Director, has disclosed no relevant financial relationships.

    Disclaimer
    The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.

    Unapproved Product Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Cephalon, sanofi-aventis U.S. Inc., and Takeda do not recommend the use of any agent outside the labeled indications.

    The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute,Cephalon, sanofi-aventis U.S. Inc., and Takeda. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Computer Requirements
    . JavaScript-enabled browser (ie, IE 4.0+, Netscape 6.0+)
    . Macromedia Flash Player 8.0
    . Broadband Internet connection (ie, cable, DSL, T1)

    Policy on Privacy and Confidentiality
    Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared or used for commercial purposes unless prior permission has been granted by the user.

    Curatio CME Institute may collect standard Web traffic data such as time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation of and issuance of certification for CME/CE tests. By participating in the Web-based activity, the user agrees that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.

    For CME questions, please contact cmeinfo@curatiocme.com or call (610) 363-1619 ext. 113. If you experience technical difficulties, please contact helpdesk@axis-healthcare.com.

Activity Material
View Presentation
Get Podcast
Get PDF of Slides
Earn Credit
Take Posttest

©2008 AXIOM Professional Health Learning

SimPatient

    Under Development — Coming Soon!